Although several molecular markers, such as Glypican-3 (GPC3), Des-γ-carboxyprothrombin (DCP), and Osteopontin (OPN), have been reported as potential diagnostic or prognostic markers of HCC, none has translated into routine clinical practice because of their limited accuracy in predicting HCC progression (12). This evidence concerns the gene ACE and hepatocellular carcinoma.